World Stroke Organization 
Join us for an insightful webinar on the critical topic of anticoagulation in stroke prevention, supported by an educational unrestricted grant from Bayer. This session will provide an overview of anticoagulation pathways, focusing on the delicate balance between risks and benefits of emerging initiatives. We will delve into the latest biomarkers for assessing AF-burden and their implications for stroke recurrence risk. Through case-based learning, participants will gain practical knowledge and strategies to address current gaps in anticoagulation therapy. Enhance your expertise and stay updated with the latest advancements in stroke prevention.
Chair: Assoc. Prof. Octavio M. Pontes Neto (Brazil)
- Overview of anticoagulation: pathways, balancing risks and benefits of new initiatives (Prof. Jeffrey Weitz, Canada)
- AF-burden biomarkers and stroke (recurrence) risk (Prof. Mira Katan, Switzerland)
- Case-based learning – Prof. Valeria Caso (Italy)
Webinar Details
Speakers:
- Prof. Valeria Caso, Consultant neurologist at the Stroke Unit of Santa Maria della Misericordia Hospital at the University of Perugia, Italy
- Prof. Jeffrey Weitz, Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University, Executive Director of the Thrombosis and Atherosclerosis Research Institute, Canada
- Prof. Mira Katan, Deputy Director Department of Neurology. Universitätsspital Basel, Switzerland
Moderator:
- Assoc. Prof. Octavio Marques Pontes Neto, Neurologist, Associate Professor of Neurology at Ribeirão Preto Medical School, University of São Paulo, Brazil
;
